Cardiol Therapeutics Signs Exclusive National Supplier Agreement with Medical Cannabis by Shoppers, a subsidiary of Shoppers Drug Mart

Investors

Press Releases

Cardiol Therapeutics Closes $17.25 Million Bought Deal Offering, Including Full Exercise of the Over-Allotment Option

June 04, 2020

Cardiol Therapeutics Reports 2020 AGM Results

June 02, 2020

Cardiol Therapeutics to Webcast Virtual Annual General Meeting on June 1st at 4:30 p.m. EDT

May 29, 2020

Cardiol Therapeutics Announces Increase to Previously Announced Bought Deal Public Offering

May 14, 2020

Cardiol Therapeutics Announces $11.25 Million Bought Deal Public Offering

May 13, 2020

Cardiol Therapeutics Files International Patent Application Covering the Use of Cannabidiol (CBD) to Improve the Outcome of Patients with COVID-19

May 06, 2020

Cardiol Therapeutics Announces Study Demonstrating its Proprietary Nanotechnology Targets Fibrous Tissue in the Heart

April 14, 2020

Cardiol Therapeutics Announces Study Results Confirm the Cardioprotective Role of its Pharmaceutical Cannabidiol Formulation in a Model of Heart Failure

April 01, 2020

Cardiol Therapeutics Announces Filing of 2019 Year-end Financial Statements and MD&A

March 26, 2020

Cardiol Therapeutics Signs Supplier Agreement with Medical Cannabis by Shoppers, a Subsidiary of Shoppers Drug Mart Inc.

March 18, 2020